Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
出版年份 2020 全文链接
标题
Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
作者
关键词
-
出版物
Cancers
Volume 12, Issue 9, Pages 2390
出版商
MDPI AG
发表日期
2020-08-24
DOI
10.3390/cancers12092390
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
- (2020) Matthias Guckenberger et al. LANCET ONCOLOGY
- CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial
- (2020) Rob Coleman et al. Trials
- Molecular imaging of bone metastases and their response to therapy
- (2020) Gary Cook et al. JOURNAL OF NUCLEAR MEDICINE
- Utilization of stereotactic ablative radiotherapy in oligometastatic & oligoprogressive skeletal metastases: Results and pattern of failure
- (2019) Tsz Yeung Kam et al. Asia-Pacific Journal of Clinical Oncology
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
- (2019) Kang Liang Zeng et al. Frontiers in Oncology
- Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: Preliminary assessment of toxicity
- (2019) Edy Ippolito et al. BREAST
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Therapeutic Irradiation: Consequences for Bone and Bone Marrow Adipose Tissue
- (2019) Samantha Costa et al. Frontiers in Endocrinology
- CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastases
- (2019) Nicholas B. Figura et al. JOURNAL OF NEURO-ONCOLOGY
- Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial
- (2019) Francesco Cellini et al. Trials
- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States
- (2018) Rohini K. Hernandez et al. BMC CANCER
- Early Tissue Effects of Stereotactic Body Radiation Therapy for Spinal Metastases
- (2018) Jasper G. Steverink et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial
- (2018) Debu Tripathy et al. LANCET ONCOLOGY
- Histopathological Findings After Reirradiation Compared to First Irradiation of Spinal Bone Metastases With Stereotactic Body Radiotherapy: A Cohort Study
- (2018) Robert Foerster et al. NEUROSURGERY
- Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial
- (2018) Marco Trovo et al. RADIOTHERAPY AND ONCOLOGY
- IMproved MAnagement (IM-MA study) in cancer-related pain: the value of a joint approach by an integrated team of radiotherapist and anesthetist
- (2018) S. Manfrida et al. SUPPORTIVE CARE IN CANCER
- Response evaluation with 18F-FDG PET/CT in metastatic breast cancer patients treated with Palbociclib: first experience in clinical practice
- (2018) Silvia Taralli et al. ANNALS OF NUCLEAR MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oligometastatic breast cancer
- (2018) Dorota Kwapisz Breast Cancer
- Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade
- (2018) Michael T. Milano et al. RADIOTHERAPY AND ONCOLOGY
- Metastatic bone disease: Pathogenesis and therapeutic options
- (2018) Stella D'Oronzo et al. Journal of Bone Oncology
- Interventional radiology in bone metastases
- (2017) J. Chiras et al. EUROPEAN JOURNAL OF CANCER CARE
- MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
- (2017) Matthew P. Goetz et al. JOURNAL OF CLINICAL ONCOLOGY
- Differences in responses to X-ray exposure between osteoclast and osteoblast cells
- (2017) Jian Zhang et al. JOURNAL OF RADIATION RESEARCH
- The impact of metastasis on the mineral phase of vertebral bone tissue
- (2017) Mikhail Burke et al. Journal of the Mechanical Behavior of Biomedical Materials
- Timing of Metastasis in Breast Cancer
- (2017) Robert S. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast carcinoma subtypes show different patterns of metastatic behavior
- (2017) István Artúr Molnár et al. VIRCHOWS ARCHIV
- Poly-(ADP-ribose)-polymerase inhibitors as radiosensitizers: a systematic review of pre-clinical and clinical human studies
- (2017) Paul Lesueur et al. Oncotarget
- Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
- (2017) Qi Wu et al. Oncotarget
- Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)
- (2016) Anthony C. Wong et al. CANCER
- Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
- (2016) Massimo Cristofanilli et al. LANCET ONCOLOGY
- Early dissemination seeds metastasis in breast cancer
- (2016) Hedayatollah Hosseini et al. NATURE
- Mechanism of early dissemination and metastasis in Her2+ mammary cancer
- (2016) Kathryn L. Harper et al. NATURE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Current Status of PARP Inhibitors in Ovarian Cancer
- (2016) Jennifer McLachlan et al. TUMORI
- Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
- (2016) Stephen R. Adams et al. Nature Communications
- HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo
- (2016) Jing Hou et al. Oncotarget
- STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers
- (2016) Jae-Sung Kim et al. Oncotarget
- Curing Metastatic Breast Cancer
- (2016) George W. Sledge Journal of Oncology Practice
- The Current Status of PARP Inhibitors in Ovarian Cancer
- (2016) Jennifer McLachlan et al. TUMORI JOURNAL
- Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
- (2015) D Di Gioia et al. BRITISH JOURNAL OF CANCER
- Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy As (neo)Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer
- (2015) Ian E. Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial
- (2015) Denise A. Yardley et al. Trials
- Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
- (2014) M. Piccart et al. ANNALS OF ONCOLOGY
- A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease
- (2014) Robert Coleman et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy
- (2014) M Li et al. ONCOGENE
- Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
- (2013) T. de Vin et al. ANNALS OF ONCOLOGY
- Radiometabolic Treatment of Bone-Metastasizing Cancer: From 186Rhenium to 223Radium
- (2013) Giuseppe Rubini et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Functional Imaging in Extrapulmonary Sarcoidosis
- (2013) Michael Soussan et al. CLINICAL NUCLEAR MEDICINE
- Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response
- (2013) Glorianne Lazaro et al. ENDOCRINE-RELATED CANCER
- A role of intracellular mono-ADP-ribosylation in cancer biology
- (2013) Emanuele S. Scarpa et al. FEBS Journal
- Can Sarcoidosis and Metastatic Bone Lesions Be Reliably Differentiated on Routine MRI?
- (2012) Sandra Leigh Moore et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Stereotactic body radiotherapy for oligometastases
- (2012) Alison C Tree et al. LANCET ONCOLOGY
- Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer
- (2012) R. J. Kimple et al. ONCOLOGIST
- Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases
- (2012) F. Alongi et al. ONCOLOGIST
- Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review
- (2012) Tadashi Kobayashi et al. Breast Cancer
- Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
- (2011) Hui-Lin Yang et al. EUROPEAN RADIOLOGY
- Update of the International Consensus on Palliative Radiotherapy Endpoints for Future Clinical Trials in Bone Metastases
- (2011) Edward Chow et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor Xenografts
- (2010) Maria J. Sambade et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Significantly Longer Progression-Free Survival Withnab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
- (2009) William J. Gradishar et al. JOURNAL OF CLINICAL ONCOLOGY
- Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis
- (2009) Colleen M Costelloe et al. LANCET ONCOLOGY
- The impact of trastuzumab on radiation-induced pulmonary fibrosis: results of an experimental study
- (2009) N. S. Bese et al. MEDICAL ONCOLOGY
- Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK
- (2009) Maria J. Sambade et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic factors and a scoring system for survival after radiotherapy for metastases to the spinal column
- (2008) Masashi Mizumoto et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search